SCHEMBL7219969

SCHEMBL7219969

NC(=O)[C@@H]1CCN(Cc2ccc3ncnc(Cl)c3c2)C1=O

nearest known ligand 0.40

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 5/20 0.38
CNR2 P34972 3/20 0.38
DGAT1 O75907 1/20 0.37
F10 P00742 9/20 0.37
JAK3 P52333 1/20 0.37
GAA P10253 1/20 0.34
ALDH1A1 P00352 1/20 0.34
MET P08581 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7452311 1.00 CNR1 (0.38) CNR1CNR2DGAT1F10JAK3
SCHEMBL7215904 0.85 MET (0.39) DGAT1F10JAK3GAAALDH1A1
SCHEMBL6221084 0.83 F10 (0.44) F10MET
SCHEMBL7453305 0.83 F10 (0.44) F10MET
SCHEMBL27502976 0.82 F10 (0.36) CNR1DGAT1F10
Trifluoroacetic Acid SCHEMBL7213639 0.82 DGAT1 (0.39) DGAT1F10
SCHEMBL6221508 0.82 F10 (0.49) DGAT1F10JAK3
SCHEMBL7921803 0.82 SMYD3 (0.40) F10ALDH1A1MET
SCHEMBL7219970 0.80 F10 (0.39) F10ALDH1A1
SCHEMBL7452322 0.80 F10 (0.39) F10ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6602864-B1 Sulfonic acid or sulfonylamino N-(heteroaralkyl)-azaheterocyclylamide compounds AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2003-08-05 US disclosed
EP-0944386-B1 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA INC (US) 2002-09-18 EP disclosed
US-6281227-B1 INHIBITORS OF THE ACTIVITY OF FACTOR XA. AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-08-28 US disclosed
WO-2001039759-A2 SULFONIC ACID OR SULFONYLAMINO N-(HETEROARALKYL)-AZAHETEROCYCLYLAMIDE COMPOUNDS AVENTIS PHARMA DEUTSCHLAND GMBH (DE) 2001-06-07 WO disclosed